Artificial intelligence news.
Straight from the original announcements.

DarioHealth Names John R. Palumbo Chairman as Care Markets Converge

November 4, 2026, 13:30By the AI News Bites Editorial TeamSource: PR Newswire
DarioHealth Names John R. Palumbo Chairman as Care Markets Converge
Image: PR Newswire

DarioHealth has appointed healthcare executive John R. Palumbo as chairman of its board, effective November 3, 2026, as the company targets a closer connection between consumer-directed healthcare and payer-funded chronic care. Palumbo will join Dario's third quarter 2026 earnings call on November 12.

Key points
  • John R. Palumbo became DarioHealth's chairman on November 3, 2026.
  • Yoav Shaked will remain on DarioHealth's board as a director.
  • Palumbo will join Dario's third quarter 2026 earnings call on November 12.
  • Dario says more than 80% of its contracted and late-stage ARR is multi-condition.
  • The company reports more than 13 billion proprietary data points.

Palumbo takes over as Dario's board chair

Palumbo joined DarioHealth's board in April 2026 and succeeds Yoav Shaked, who had served as chairman since 2018. Shaked will remain a director.

According to DarioHealth, Palumbo brings more than 40 years of healthcare operating experience across early-stage ventures and Fortune 100 enterprises. His previous leadership roles include AmerisourceBergen Corporation, now Cencora, Inc., where he led the provider business unit, and Allscripts Healthcare Solutions, Inc., now Veradigm, Inc., where he served as chief operating officer. He also held leadership positions at Shared Medical Systems Corporation, now Oracle.

The company said Palumbo supported two companies through initial public offerings and led large-scale operational and commercial transformations. He currently serves on the boards of PM Pediatrics Management Group, Lucid Diagnostics, ivWatch and Qless, and chairs the advisory board of Brado Cuneo Nollau.

Dario targets the overlap between consumers and payers

DarioHealth said consumers are increasingly entering healthcare through AI tools, home testing and direct access to branded men's and women's health therapies. At the same time, payers continue to fund management of underlying chronic conditions, which the company says account for roughly 90% of U.S. health spending.

The company pointed to the Centers for Medicare and Medicaid Services' ACCESS Model, launched in July 2026. The model pays for outcomes in hypertension, diabetes, musculoskeletal conditions and depression, areas that align with Dario's chronic care management offerings.

Dario's chief executive, Erez Raphael, said the company had spent a decade building a platform where consumer health and chronic care meet. Palumbo described the strategic opportunity this way: “The consumer picks the door. The payer pays for the chronic condition behind it.”

Platform combines engagement, data and clinical care

Dario says its system combines DarioIQ intelligence with Dario Care clinical services, using one clinical engine and one evidence base across conditions. More than 80% of its contracted and late-stage annual recurring revenue is multi-condition, according to the company.

The platform includes FDA-cleared connected devices in members' homes and more than 13 billion proprietary data points collected over more than a decade. Dario also reports more than 100 scientific studies and more than 180 signed enterprise accounts, including more than a dozen health plans.

The company cites published evidence including $5,077 in annual savings per user and 23.5% fewer inpatient discharges among members with type 2 diabetes. It also points to an independent Aon review of 17 studies that supported a 2.5% to 7.2% in-year reduction in total healthcare costs. Dario says approximately 75% of new accounts come through channel partners.

What the appointment means for Dario's strategy

DarioHealth says the convergence could move chronic care management from single-condition applications toward an AI-led, clinician-backed and reimbursable system, with one member record accessible through either a consumer or payer entry point. The company presents its integrated platform as the basis for serving health plans, health systems and employers across diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.

Palumbo is scheduled to share the board's perspective on these market shifts and Dario's strategic priorities during the November 12 earnings call. The company cautions that its statements about market changes, reimbursement, platform adoption, clinical benefits and future growth are forward-looking and may be affected by regulatory approvals, demand, competition, product development and other risks.

DarioHealth Corp.DarioJohn R. PalumboErez RaphaelCenters for Medicare and Medicaid Serviceshealthcareenterprise AI

Related news

Dario partners with WebMD to expand AI-powered chronic care platform
BusinessNovember 19, 2026, 13:30

Dario partners with WebMD to expand AI-powered chronic care platform

DarioHealth is partnering with WebMD Health Services to bring its AI-powered, multi-condition care platform to WebMD's network of 3,500 employers and 65 million covered…

DarioHealth Adds Dario Women to Minnesota Star Tribune Employee Benefits
BusinessNovember 18, 2026, 13:30

DarioHealth Adds Dario Women to Minnesota Star Tribune Employee Benefits

DarioHealth has expanded its existing agreement with The Minnesota Star Tribune to add Dario Women, its digital health and clinical care program for women navigating…

DarioHealth unveils claims-free method to estimate healthcare savings
ResearchNovember 16, 2026, 13:30

DarioHealth unveils claims-free method to estimate healthcare savings

DarioHealth has presented research on a biometric-driven method for estimating healthcare cost savings and return on investment without waiting for medical claims data.…